What is Ibogaine?
A naturally occurring psychoactive compound with unique therapeutic potential for addiction, mental health, and neurodegenerative conditions — backed by 40+ years of clinical research.
First Anti-Addiction Study
Neurotransmitter Systems
Withdrawal Relief
12-Mo. Abstinence
From African Rainforest to Modern Medicine
Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of Tabernanthe iboga, a perennial rainforest shrub native to West Central Africa, particularly Gabon, Cameroon, and the Congo.
For centuries, the Bwiti people of Gabon have used iboga in spiritual ceremonies and rites of passage. The plant is central to their religious practices, used to facilitate connection with ancestors and spiritual realms.
In the 1960s, American researcher Howard Lotsof — himself struggling with heroin addiction — accidentally discovered ibogaine's anti-addictive properties. After a single ibogaine experience, he found his withdrawal symptoms and cravings had vanished, sparking decades of clinical investigation.
Tabernanthe iboga — sacred plant of the Bwiti tradition
Complex Mechanisms of Action
Ibogaine interacts with multiple neurotransmitter systems simultaneously — creating a unique therapeutic window unlike any conventional medication
Serotonin Receptors
Mood & PerceptionActs as a serotonin reuptake inhibitor and binds to multiple 5-HT receptor subtypes, influencing mood regulation, emotional processing, and the visionary aspects of the experience.
Opioid Receptors
Addiction PathwaysModulates mu, kappa, and delta opioid receptors without causing physical dependence, interrupting addiction cycles and eliminating withdrawal symptoms.
NMDA Receptors
NeuroplasticityActs as an NMDA receptor antagonist, potentially facilitating memory reconsolidation and allowing the brain to "rewrite" maladaptive patterns.
Dopamine System
Reward CircuitsModulates dopamine transporter activity and D2/D3 receptors, normalizing reward processing and reducing compulsive drug-seeking behavior.
Acetylcholine
CognitionInteracts with nicotinic acetylcholine receptors, potentially contributing to cognitive effects and the introspective quality of the experience.
Noribogaine
Active MetaboliteThe primary metabolite with a longer half-life (30+ hours), contributing to sustained anti-craving effects and mood stabilization for weeks or months.
The Ibogaine Experience
Treatment typically unfolds in distinct phases over 24-36 hours, each with unique therapeutic characteristics
Acute Visionary PhaseHours 1-8
Patients enter a dream-like state characterized by vivid waking dreams and introspective visions. This phase often involves deep psychological processing, memory review, and emotional release. Many describe it as "watching the movie of your life" — gaining insights into behavioral patterns, trauma origins, and relationship dynamics.
- Visionary state with eyes closed or open
- Deep introspection and memory processing
- Psychological insights and emotional breakthroughs
Cognitive Evaluation PhaseHours 8-24
Visionary intensity subsides, transitioning into a reflective period of deep clarity. Patients process the insights gained during the acute phase, often experiencing profound realizations about life choices, relationships, and behavioral patterns. Physical withdrawal symptoms are typically absent or minimal during this phase.
- Reduced visionary activity, increased mental clarity
- Integration of psychological insights
- Minimal or absent withdrawal symptoms
Post-Acute RecoveryDays 2-30+
Patients experience continued freedom from cravings and withdrawal, supported by the active metabolite noribogaine. This phase involves integration work, lifestyle changes, and often participation in aftercare programs. Many report sustained improvements in mood, motivation, and psychological well-being for months following treatment.
- Sustained reduction in cravings and withdrawal
- Integration and lifestyle implementation
- Noribogaine's therapeutic effects continue for weeks
Important Safety Considerations
Ibogaine treatment carries significant cardiac risks and is not suitable for everyone. Safe treatment requires:
- Comprehensive medical screening including EKG, blood work, and health history evaluation
- 24/7 medical monitoring during treatment with experienced staff and emergency equipment
- Careful evaluation of contraindications including cardiac conditions, medications, and health history
- Treatment only in qualified medical facilities with proper safety protocols
Ready to Learn More?
Explore comprehensive guides on therapeutic applications, research evidence, and treatment options